Annual CFO
-$7.63 M
+$5.17 M+40.41%
December 1, 2023
Summary
- As of February 7, 2025, PTPI annual cash flow from operations is -$7.63 million, with the most recent change of +$5.17 million (+40.41%) on December 1, 2023.
- During the last 3 years, PTPI annual CFO has risen by +$7.68 million (+50.17%).
- PTPI annual CFO is now -401.15% below its all-time high of $2.53 million, reached on December 31, 2019.
Performance
PTPI Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$771.20 K
+$891.20 K+53.61%
September 1, 2024
Summary
- As of February 7, 2025, PTPI quarterly cash flow from operations is -$771.20 thousand, with the most recent change of +$891.20 thousand (+53.61%) on September 1, 2024.
- Over the past year, PTPI quarterly CFO has increased by +$3.27 million (+80.94%).
- PTPI quarterly CFO is now -72.68% below its all-time high of -$446.60 thousand, reached on March 31, 2021.
Performance
PTPI Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$5.83 M
+$3.27 M+35.98%
September 1, 2024
Summary
- As of February 7, 2025, PTPI TTM cash flow from operations is -$5.83 million, with the most recent change of +$3.27 million (+35.98%) on September 1, 2024.
- Over the past year, PTPI TTM CFO has increased by +$1.11 million (+15.98%).
- PTPI TTM CFO is now -145.37% below its all-time high of -$2.38 million, reached on March 31, 2020.
Performance
PTPI TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
PTPI Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +40.4% | +80.9% | +16.0% |
3 y3 years | +50.2% | -3.0% | +29.5% |
5 y5 years | -401.1% | -3.0% | +29.5% |
PTPI Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +40.4% | -34.8% | +90.7% | -25.6% | +70.2% |
5 y | 5-year | -401.1% | +50.2% | -72.7% | +90.7% | -145.4% | +70.2% |
alltime | all time | -401.1% | +50.2% | -72.7% | +90.7% | -145.4% | +70.2% |
Petros Pharmaceuticals Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$771.20 K(-53.6%) | -$5.83 M(-36.0%) |
Jun 2024 | - | -$1.66 M(+46.5%) | -$9.10 M(+13.6%) |
Mar 2024 | - | -$1.13 M(-49.8%) | -$8.01 M(+5.1%) |
Dec 2023 | -$7.63 M(-40.4%) | -$2.26 M(-44.1%) | -$7.63 M(+9.9%) |
Sep 2023 | - | -$4.05 M(+607.3%) | -$6.94 M(+49.4%) |
Jun 2023 | - | -$572.10 K(-23.6%) | -$4.64 M(-43.9%) |
Mar 2023 | - | -$748.40 K(-52.3%) | -$8.27 M(-35.4%) |
Dec 2022 | -$12.80 M | -$1.57 M(-10.3%) | -$12.80 M(-34.5%) |
Sep 2022 | - | -$1.75 M(-58.3%) | -$19.53 M(+2.8%) |
Jun 2022 | - | -$4.20 M(-20.4%) | -$18.99 M(+13.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$5.28 M(-36.5%) | -$16.69 M(+40.7%) |
Dec 2021 | -$11.86 M(-22.5%) | -$8.30 M(+585.5%) | -$11.86 M(+46.8%) |
Sep 2021 | - | -$1.21 M(-36.2%) | -$8.08 M(-15.3%) |
Jun 2021 | - | -$1.90 M(+325.4%) | -$9.54 M(-28.7%) |
Mar 2021 | - | -$446.60 K(-90.1%) | -$13.38 M(-12.6%) |
Dec 2020 | -$15.31 M(-704.4%) | -$4.52 M(+69.6%) | -$15.31 M(+41.9%) |
Sep 2020 | - | -$2.67 M(-53.5%) | -$10.78 M(+32.9%) |
Jun 2020 | - | -$5.74 M(+141.7%) | -$8.12 M(+241.7%) |
Mar 2020 | - | -$2.38 M | -$2.38 M |
Dec 2019 | $2.53 M | - | - |
FAQ
- What is Petros Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals annual CFO year-on-year change?
- What is Petros Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals quarterly CFO year-on-year change?
- What is Petros Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals TTM CFO year-on-year change?
What is Petros Pharmaceuticals annual cash flow from operations?
The current annual CFO of PTPI is -$7.63 M
What is the all time high annual CFO for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high annual cash flow from operations is $2.53 M
What is Petros Pharmaceuticals annual CFO year-on-year change?
Over the past year, PTPI annual cash flow from operations has changed by +$5.17 M (+40.41%)
What is Petros Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of PTPI is -$771.20 K
What is the all time high quarterly CFO for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high quarterly cash flow from operations is -$446.60 K
What is Petros Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, PTPI quarterly cash flow from operations has changed by +$3.27 M (+80.94%)
What is Petros Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of PTPI is -$5.83 M
What is the all time high TTM CFO for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high TTM cash flow from operations is -$2.38 M
What is Petros Pharmaceuticals TTM CFO year-on-year change?
Over the past year, PTPI TTM cash flow from operations has changed by +$1.11 M (+15.98%)